LY-294002 targets an important pathway often mutated in GBM, the PI3K/Akt pathway [11], which appears particularly important in glioblastoma proliferation but also plays a central role in the regulation of tumor cell survival, motility, angiogenesis and metabolism [12]. This evidence concerns the gene PIK3CG and neoplasm.